| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A phase 1 trial to determine the maximum tolerated dose and patient-specific dosimetry of [177Lu]Lu-LNC1003 in patients with metastatic castration-resistant prostate cancer
|
Zang, Jie
|
|
|
51 |
3 |
p. 871-882
|
article
|
| 2 |
A Practical Guide for Pediatric Nuclear Medicine. Zvi Bar-Sever, Francesco Giammarile, Ora Israel, Helen Nadel (Editors). OPEN ACCESS
|
Mansi, Luigi
|
|
|
51 |
3 |
p. 611
|
article
|
| 3 |
A single-center, multi-factor, retrospective study to improve the diagnostic accuracy of primary prostate cancer using [68Ga]Ga-PSMA-11 total-body PET/CT imaging
|
Lv, Jing
|
|
|
51 |
3 |
p. 919-927
|
article
|
| 4 |
Assessing dynamic metabolic heterogeneity in prostate cancer patients via total-body [68Ga]Ga-PSMA-11 PET/CT imaging: quantitative analysis of [68Ga]Ga-PSMA-11 uptake in pathological lesions and normal organs
|
Chen, Ruohua
|
|
|
51 |
3 |
p. 896-906
|
article
|
| 5 |
Brain perfusion estimation by Tikhonov model-free deconvolution in a long axial field of view PET/CT scanner exploring five different PET tracers
|
Larsson, Henrik Bo Wiberg
|
|
|
51 |
3 |
p. 707-720
|
article
|
| 6 |
Cardiac [99mTc]Tc-hydroxydiphosphonate uptake on bone scintigraphy in patients with hereditary transthyretin amyloidosis: an early follow-up marker?
|
Tingen, H. S. A.
|
|
|
51 |
3 |
p. 681-690
|
article
|
| 7 |
Change in total lesion PSMA (TLP) during [177Lu]Lu-PSMA-617 radioligand therapy predicts overall survival in patients with mCRPC: monocentric evaluation of a prospective registry
|
Burgard, Caroline
|
|
|
51 |
3 |
p. 885-895
|
article
|
| 8 |
Changes in tumor-to-blood ratio as a prognostic marker for progression-free survival and overall survival in neuroendocrine tumor patients undergoing PRRT
|
Weber, Manuel
|
|
|
51 |
3 |
p. 841-851
|
article
|
| 9 |
Chemokine receptor–targeted PET/CT provides superior diagnostic performance in newly diagnosed marginal zone lymphoma patients: a head-to-head comparison with [18F]FDG
|
Kosmala, Aleksander
|
|
|
51 |
3 |
p. 749-755
|
article
|
| 10 |
CT attenuation correction improves quantitative risk prediction by cardiac SPECT in obese patients
|
Feher, Attila
|
|
|
51 |
3 |
p. 695-706
|
article
|
| 11 |
Development of a novel 18F-labeled small molecule probe for PET imaging of mesenchymal epithelial transition receptor expression
|
Bu, Lihong
|
|
|
51 |
3 |
p. 656-668
|
article
|
| 12 |
Development of novel peptide-based radiotracers for detecting PD-L1 expression and guiding cancer immunotherapy
|
Zhu, Shiyu
|
|
|
51 |
3 |
p. 625-640
|
article
|
| 13 |
Diagnostic accuracy of fully hybrid [68Ga]Ga-PSMA-11 PET/MRI and [68Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial
|
Ghezzo, Samuele
|
|
|
51 |
3 |
p. 907-918
|
article
|
| 14 |
Epithelioid granuloma mimicking lung cancer showed intense uptake on [18F]FAPI-74 PET
|
Watabe, Tadashi
|
|
|
51 |
3 |
p. 930-931
|
article
|
| 15 |
Exploring the association of glioma tumor residuals from incongruent [18F]FET PET/MR imaging with tumor proliferation using a multiparametric MRI radiomics nomogram
|
Li, Xiaoran
|
|
|
51 |
3 |
p. 779-796
|
article
|
| 16 |
FAPI PET/CT: a new kid on the block for RCC
|
Udovicich, Cristian
|
|
|
51 |
3 |
p. 862-863
|
article
|
| 17 |
[18F]FET PET/MR and machine learning in the evaluation of glioma
|
Piscopo, Leandra
|
|
|
51 |
3 |
p. 797-799
|
article
|
| 18 |
From pixels to predictions: the scrying power of molecular imaging
|
Ninatti, Gaia
|
|
|
51 |
3 |
p. 618-624
|
article
|
| 19 |
Impact of simulated reduced injected dose on the assessment of amyloid PET scans
|
Young, Peter
|
|
|
51 |
3 |
p. 734-748
|
article
|
| 20 |
Letter to the Editor: Postoperative thyroglobulin as a yard-stick for radioiodine therapy: decision tree analysis in a European multicenter series of 1317 patients with differentiated thyroid cancer
|
Sasaki, Fernanda Miyuki
|
|
|
51 |
3 |
p. 803-804
|
article
|
| 21 |
Metastatic castration-resistant prostate cancer therapy: the quest for the perfect molecule
|
Bianco, Davide
|
|
|
51 |
3 |
p. 883-884
|
article
|
| 22 |
Mono- and multimeric PSMA-targeting small molecule-thorium-227 conjugates for optimized efficacy and biodistribution in preclinical models
|
Böhnke, Niels
|
|
|
51 |
3 |
p. 669-680
|
article
|
| 23 |
PET/CT imaging with radiolabeled FAPI: new opportunities for diagnosis and treatment of thyroid cancer
|
Piscopo, Leandra
|
|
|
51 |
3 |
p. 800-802
|
article
|
| 24 |
Pigmented villonodular synovitis detected by [68Ga]Ga-FAPI-04 PET/CT
|
Guo, Chunmei
|
|
|
51 |
3 |
p. 928-929
|
article
|
| 25 |
p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
|
Berglund, Hanna
|
|
|
51 |
3 |
p. 768-778
|
article
|
| 26 |
Simultaneous high-resolution whole-brain MR spectroscopy and [18F]FDG PET for temporal lobe epilepsy
|
Huang, Hui
|
|
|
51 |
3 |
p. 721-733
|
article
|
| 27 |
Something still missing in molecular imaging: CXCR2 axis in prostate cancer
|
Filippi, Luca
|
|
|
51 |
3 |
p. 615-617
|
article
|
| 28 |
STING-targeted PET tracer for early assessment of tumor immunogenicity in colorectal cancer after chemotherapy
|
Xu, Duo
|
|
|
51 |
3 |
p. 641-655
|
article
|
| 29 |
The cycle effect quantified: reduced tumour uptake in subsequent cycles of [177Lu]Lu-HA-DOTATATE during peptide receptor radionuclide therapy
|
Siebinga, H.
|
|
|
51 |
3 |
p. 820-827
|
article
|
| 30 |
The evidence-based role of catecholaminergic PET tracers in Neuroblastoma. A systematic review and a head-to-head comparison with mIBG scintigraphy
|
Piccardo, Arnoldo
|
|
|
51 |
3 |
p. 756-767
|
article
|
| 31 |
The inferior performance of [68Ga]Ga-FAPI-04 PET/CT as a diagnostic and theranostic biomarker in [177Lu]Lu-DOTATATE refractory well-differentiated neuroendocrine tumors
|
Has Simsek, Duygu
|
|
|
51 |
3 |
p. 828-840
|
article
|
| 32 |
The prognostic role of next-generation imaging-driven upstaging in newly diagnosed prostate cancer patients
|
Bauckneht, Matteo
|
|
|
51 |
3 |
p. 864-870
|
article
|
| 33 |
Therapeutic potential of [177Lu]Lu-DOTAGA-FAPi dimers in metastatic breast cancer patients with limited treatment options: efficacy and safety assessment
|
Yadav, Madhav P.
|
|
|
51 |
3 |
p. 805-819
|
article
|
| 34 |
The role of [68 Ga]Ga-FAPI-04 PET/CT in renal cell carcinoma: a preliminary study
|
Civan, Caner
|
|
|
51 |
3 |
p. 852-861
|
article
|
| 35 |
The 16th Hangzhou International Molecular Imaging Conference (HIMIC 2023): the milestone of molecular imaging journey in China
|
Tian, Mei
|
|
|
51 |
3 |
p. 612-614
|
article
|
| 36 |
Treatment response assessment in transthyretin-related cardiac amyloidosis: an emerging clinical indication of bone-seeking radiopharmaceuticals?
|
Gheysens, Olivier
|
|
|
51 |
3 |
p. 691-694
|
article
|
Journal description